Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision label `Revision: v3.4.2` has been added. The previously displayed government funding status notice (lapse in funding) has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice regarding government funding and a revision update from v3.4.0 to v3.4.1 were added. No study content, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI/metadata changes include showing a glossary, adding Last Update Submitted that Met QC Criteria, adding No FEAR Act Data, and Revision: v3.4.0, while removing the older QC label and Revision: v3.3.4. These updates do not affect core trial details such as title, conditions, endpoints, eligibility criteria, locations, or study results.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This is a minor maintenance update with no changes to the page's core content or study information.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter text updated to Revision: v3.3.3; the HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.